DEXLANSOPRAZOLE

DEXLANSOPRAZOLE was reported 41740 times

These side effects are most commonly reported by patients taking DEXLANSOPRAZOLE:

# Side effect Count
0 CHRONIC KIDNEY DISEASE 16103
1 ACUTE KIDNEY INJURY 7811
2 RENAL FAILURE 6722
3 END STAGE RENAL DISEASE 4888
4 RENAL INJURY 4339
5 DRUG INEFFECTIVE 2631
6 FATIGUE 2445
7 OFF LABEL USE 2345
8 NAUSEA 2247
9 TUBULOINTERSTITIAL NEPHRITIS 2191
10 DIARRHOEA 2011
11 HEADACHE 1973
12 PAIN 1967
13 DEATH 1887
14 DYSPNOEA 1653
15 GASTROOESOPHAGEAL REFLUX DISEASE 1465
16 ARTHRALGIA 1444
17 DIZZINESS 1217
18 VOMITING 1187
19 COUGH 1182
20 ABDOMINAL PAIN 1178
21 REBOUND ACID HYPERSECRETION 1167
22 PNEUMONIA 1148
23 CONDITION AGGRAVATED 1132
24 MALAISE 1115
25 ASTHENIA 1101
26 ABDOMINAL PAIN UPPER 894
27 WEIGHT DECREASED 893
28 PAIN IN EXTREMITY 884
29 DRUG HYPERSENSITIVITY 849
30 NEPHROGENIC ANAEMIA 840
31 PYREXIA 821
32 CONSTIPATION 803
33 HYPERTENSION 788
34 ASTHMA 787
35 RENAL HAEMANGIOMA 786
36 RASH 772
37 PRURITUS 766
38 BACK PAIN 764
39 HYPERCHLORHYDRIA 755
40 NASOPHARYNGITIS 749
41 FALL 739
42 RENAL IMPAIRMENT 725
43 PERIPHERAL SWELLING 722
44 DEPRESSION 691
45 INSOMNIA 688
46 DRUG INTOLERANCE 669
47 ANXIETY 642
48 ANAEMIA 630
49 MUSCULOSKELETAL STIFFNESS 621
50 ERYTHEMA 610
51 WEIGHT INCREASED 606
52 BLOOD PRESSURE INCREASED 594
53 ABDOMINAL DISCOMFORT 591
54 DYSPEPSIA 581
55 DECREASED APPETITE 577
56 REBOUND EFFECT 576
57 GENERAL PHYSICAL HEALTH DETERIORATION 562
58 ABDOMINAL DISTENSION 557
59 PRODUCT DOSE OMISSION ISSUE 549
60 PRODUCT USE ISSUE 530
61 SOMNOLENCE 529
62 URINARY TRACT INFECTION 526
63 FEELING ABNORMAL 524
64 ARTHRITIS 522
65 MUSCLE SPASMS 516
66 PRODUCT USE IN UNAPPROVED INDICATION 514
67 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 506
68 CHEST PAIN 503
69 HYPERSENSITIVITY 493
70 SINUSITIS 493
71 TREMOR 489
72 JOINT SWELLING 470
73 RHEUMATOID ARTHRITIS 470
74 COVID-19 458
75 OEDEMA PERIPHERAL 457
76 STRESS 457
77 MYALGIA 453
78 OROPHARYNGEAL PAIN 445
79 ALOPECIA 444
80 INJECTION SITE PAIN 441
81 NO ADVERSE EVENT 439
82 DRY MOUTH 431
83 BRONCHITIS 413
84 MIGRAINE 413
85 GAIT DISTURBANCE 411
86 SWELLING 398
87 HYPOTENSION 396
88 HYPERPARATHYROIDISM SECONDARY 392
89 WHEEZING 391
90 INFECTION 388
91 URTICARIA 385
92 BLOOD CREATININE INCREASED 384
93 THROMBOSIS 381
94 UPPER RESPIRATORY TRACT INFECTION 381
95 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 373
96 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 365
97 HYPOAESTHESIA 363
98 BLOOD PRESSURE SYSTOLIC INCREASED 362
99 INFUSION RELATED REACTION 362
100 ULCER 361
101 INFLUENZA 359
102 INTENTIONAL PRODUCT USE ISSUE 357
103 PSORIATIC ARTHROPATHY 356
104 DIABETES MELLITUS 352
105 HEART RATE INCREASED 342
106 LOWER RESPIRATORY TRACT INFECTION 341
107 RHINORRHOEA 338
108 INFLAMMATION 334
109 SEPSIS 333
110 PALPITATIONS 329
111 CHEST DISCOMFORT 318
112 DEHYDRATION 318
113 PARAESTHESIA 310
114 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 310
115 CROHN^S DISEASE 308
116 ASPARTATE AMINOTRANSFERASE INCREASED 304
117 ILLNESS 298
118 CHILLS 295
119 PSORIASIS 294
120 SYNOVITIS 293
121 GASTROINTESTINAL DISORDER 291
122 SLEEP DISORDER 291
123 MUSCULAR WEAKNESS 290
124 RASH PRURITIC 282
125 NECK PAIN 278
126 NASAL CONGESTION 277
127 TREATMENT FAILURE 277
128 MOBILITY DECREASED 275
129 HYPERHIDROSIS 272
130 SPUTUM DISCOLOURED 272
131 INTENTIONAL PRODUCT MISUSE 271
132 NEPHROPATHY 269
133 PRODUCTIVE COUGH 269
134 DYSPHONIA 267
135 PULMONARY EMBOLISM 265
136 INCORRECT DOSE ADMINISTERED 263
137 CONFUSIONAL STATE 258
138 DRUG DOSE OMISSION 252
139 C-REACTIVE PROTEIN INCREASED 251
140 HAEMATOCHEZIA 251
141 SKIN ULCER 251
142 ALANINE AMINOTRANSFERASE INCREASED 250
143 BLOOD TEST ABNORMAL 249
144 DYSPHAGIA 248
145 TENOSYNOVITIS 246
146 LUNG DISORDER 242
147 FEBRILE NEUTROPENIA 241
148 INCORRECT PRODUCT ADMINISTRATION DURATION 241
149 PLEURAL EFFUSION 241
150 WHITE BLOOD CELL COUNT DECREASED 241
151 BLOOD CHOLESTEROL INCREASED 240
152 MYOCARDIAL INFARCTION 240
153 HAEMOGLOBIN DECREASED 238
154 VISUAL IMPAIRMENT 237
155 HOSPITALISATION 236
156 NEPHROLITHIASIS 235
157 HEART RATE DECREASED 234
158 TENDONITIS 234
159 MUSCULOSKELETAL PAIN 232
160 CONTUSION 231
161 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 230
162 ARTHROPATHY 229
163 NEURALGIA 229
164 BLOOD PRESSURE FLUCTUATION 227
165 THERAPEUTIC PRODUCT EFFECT DECREASED 227
166 MEMORY IMPAIRMENT 226
167 C-REACTIVE PROTEIN ABNORMAL 224
168 HYPONATRAEMIA 224
169 JOINT INJURY 224
170 PULMONARY FIBROSIS 220
171 VISION BLURRED 219
172 LOSS OF CONSCIOUSNESS 218
173 BACTERIAL INFECTION 217
174 OVERDOSE 212
175 BLOOD CALCIUM INCREASED 210
176 BURNING SENSATION 210
177 CEREBROVASCULAR ACCIDENT 210
178 FLATULENCE 210
179 ATRIAL FIBRILLATION 208
180 DRUG DEPENDENCE 206
181 BALANCE DISORDER 204
182 ENTHESOPATHY 200
183 TONGUE DISORDER 200
184 FEELING HOT 198
185 INJECTION SITE ERYTHEMA 197
186 TACHYCARDIA 197
187 CARDIAC DISORDER 194
188 RENAL DISORDER 194
189 THERAPY NON-RESPONDER 194
190 OSTEOARTHRITIS 193
191 ASPIRATION 191
192 FLUSHING 190
193 DYSPNOEA EXERTIONAL 189
194 MULTIPLE ORGAN DYSFUNCTION SYNDROME 189
195 OBSTRUCTIVE AIRWAYS DISORDER 188
196 HAEMOPTYSIS 187
197 ASCITES 186
198 CONTRAINDICATED PRODUCT ADMINISTERED 186
199 RHEUMATOID NODULE 186
200 VERTIGO 186
201 INFLUENZA LIKE ILLNESS 184
202 THERAPY INTERRUPTED 183
203 GOUT 182
204 SYNCOPE 182
205 BLOOD PRESSURE DECREASED 181
206 BRONCHIECTASIS 181
207 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 180
208 MYASTHENIA GRAVIS 180
209 APPENDICITIS 179
210 LIVER FUNCTION TEST INCREASED 179
211 HOT FLUSH 178
212 SWELLING FACE 178
213 BASAL CELL CARCINOMA 176
214 OXYGEN SATURATION DECREASED 176
215 ADVERSE EVENT 175
216 COLITIS ULCERATIVE 175
217 DRY EYE 175
218 GASTRIC DISORDER 175
219 HYPERPHOSPHATAEMIA 175
220 HYPOPHOSPHATAEMIA 175
221 THROAT IRRITATION 175
222 TRANSAMINASES INCREASED 175
223 CARDIOGENIC SHOCK 172
224 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 171
225 LUNG OPACITY 171
226 VENTRICULAR FIBRILLATION 171
227 BLOOD GLUCOSE INCREASED 169
228 CATARACT 168
229 DISCOMFORT 168
230 NEUROPATHY PERIPHERAL 168
231 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 168
232 OSTEOPOROSIS 166
233 PLEURITIC PAIN 166
234 APPENDICOLITH 164
235 EYE PAIN 164
236 LIVER DISORDER 162
237 BLOOD URIC ACID INCREASED 161
238 HYPERCALCAEMIA 161
239 DRUG ERUPTION 158
240 HYPOXIA 158
241 DEVICE MALFUNCTION 157
242 BLOOD PHOSPHORUS INCREASED 156
243 DRY SKIN 156
244 CLOSTRIDIUM DIFFICILE INFECTION 155
245 DYSURIA 152
246 PULMONARY MASS 151
247 SURGERY 151
248 HERPES ZOSTER 150
249 ALANINE AMINOTRANSFERASE ABNORMAL 149
250 PANNICULITIS 149
251 SKIN NECROSIS 149
252 BLOOD PARATHYROID HORMONE DECREASED 147
253 CORONARY ARTERY DISEASE 147
254 HYPERLIPIDAEMIA 147
255 IRON DEFICIENCY 147
256 OCULAR HYPERAEMIA 147
257 TOTAL LUNG CAPACITY DECREASED 147
258 POLLAKIURIA 146
259 HEPATIC ENZYME INCREASED 145
260 THERAPEUTIC RESPONSE SHORTENED 143
261 BODY TEMPERATURE DECREASED 142
262 FREQUENT BOWEL MOVEMENTS 142
263 EXTRA DOSE ADMINISTERED 141
264 EPISTAXIS 140
265 INTESTINAL OBSTRUCTION 139
266 ANALGESIC THERAPY 138
267 NEOPLASM MALIGNANT 137
268 CELLULITIS 136
269 DRUG INTERACTION 136
270 EAR INFECTION 135
271 FULL BLOOD COUNT ABNORMAL 135
272 THERAPEUTIC RESPONSE DECREASED 135
273 DIVERTICULITIS 134
274 KIDNEY INFECTION 134
275 RED BLOOD CELL SEDIMENTATION RATE INCREASED 134
276 CARDIAC FAILURE CONGESTIVE 133
277 FIBROMYALGIA 133
278 BLOOD PRESSURE DIASTOLIC DECREASED 132
279 HAEMORRHAGE 132
280 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 131
281 GASTRITIS 130
282 RALES 129
283 SLEEP DISORDER THERAPY 129
284 GRANULOMA SKIN 128
285 DRUG THERAPY 127
286 HEART RATE IRREGULAR 127
287 PRODUCT QUALITY ISSUE 127
288 INJECTION SITE BRUISING 124
289 DYSGEUSIA 123
290 INTERSTITIAL LUNG DISEASE 123
291 OEDEMA 123
292 GASTROINTESTINAL HAEMORRHAGE 122
293 MICTURITION URGENCY 122
294 STOMATITIS 122
295 AMNESIA 121
296 VIRAL INFECTION 121
297 ENDOMETRIOSIS 118
298 SEIZURE 118
299 TOXICITY TO VARIOUS AGENTS 118
300 RED BLOOD CELL COUNT DECREASED 117
301 SYSTEMIC LUPUS ERYTHEMATOSUS 117
302 HIATUS HERNIA 116
303 LIMB INJURY 115
304 NERVOUSNESS 115
305 RECTAL HAEMORRHAGE 115
306 RED BLOOD CELL SEDIMENTATION RATE 115
307 COLITIS 114
308 PLATELET COUNT DECREASED 113
309 BONE PAIN 111
310 EYE IRRITATION 110
311 INJECTION SITE HAEMORRHAGE 110
312 INJECTION SITE MASS 109
313 INJECTION SITE REACTION 109
314 SUICIDAL IDEATION 108
315 AORTIC STENOSIS 106
316 TRANSIENT ISCHAEMIC ATTACK 106
317 ADVERSE DRUG REACTION 105
318 BLOOD PRESSURE DIASTOLIC ABNORMAL 105
319 CYSTITIS 105
320 DEVICE DISLOCATION 105
321 FAECES SOFT 105
322 ILL-DEFINED DISORDER 105
323 UNEVALUABLE EVENT 105
324 URINARY INCONTINENCE 105
325 EMOTIONAL DISTRESS 104
326 IRRITABLE BOWEL SYNDROME 103
327 TROPONIN INCREASED 103
328 FEAR OF INJECTION 102
329 PRODUCT DOSE OMISSION 102
330 DEVICE ISSUE 101
331 IMPAIRED GASTRIC EMPTYING 101
332 PANCREATITIS 101
333 SKIN EXFOLIATION 101
334 EAR PAIN 100
335 ORAL HERPES 100
336 SWOLLEN TONGUE 100
337 BLOOD POTASSIUM DECREASED 99
338 DISEASE RECURRENCE 99
339 NEUTROPENIA 99
340 FEEDING DISORDER 98
341 HAEMATURIA 98
342 SPEECH DISORDER 98
343 INJECTION SITE SWELLING 97
344 OSTEOMYELITIS 97
345 BLISTER 96
346 BURSITIS 96
347 BONE DENSITY DECREASED 95
348 DISTURBANCE IN ATTENTION 95
349 HYPOKALAEMIA 95
350 MUSCULOSKELETAL DISORDER 95
351 ROAD TRAFFIC ACCIDENT 95
352 ANTICOAGULANT THERAPY 94
353 FOOT FRACTURE 94
354 RENAL CYST 94
355 ANTACID THERAPY 93
356 POOR VENOUS ACCESS 93
357 TINNITUS 93
358 ANAPHYLACTIC REACTION 92
359 THROAT TIGHTNESS 92
360 DRUG SPECIFIC ANTIBODY 90
361 INCORRECT DRUG ADMINISTRATION DURATION 90
362 RENAL TUBULAR NECROSIS 90
363 ATELECTASIS 89
364 GASTRIC ULCER 89
365 HAEMORRHOIDS 89
366 ACNE 88
367 CHROMATURIA 88
368 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 87
369 LYMPHADENOPATHY 87
370 FEELING JITTERY 86
371 PRODUCT SUBSTITUTION ISSUE 86
372 CARDIOVASCULAR DISORDER 85
373 GASTRIC CANCER 85
374 IMPAIRED WORK ABILITY 85
375 LIMB DISCOMFORT 85
376 SEASONAL ALLERGY 84
377 CARDIAC FAILURE 83
378 CARPAL TUNNEL SYNDROME 83
379 DIALYSIS 83
380 FUNGAL INFECTION 83
381 THERAPEUTIC RESPONSE UNEXPECTED 83
382 HYPERCHOLESTEROLAEMIA 82
383 MOVEMENT DISORDER 82
384 PAIN IN JAW 82
385 RASH MACULAR 82
386 SLEEP APNOEA SYNDROME 82
387 BLOOD IRON DECREASED 81
388 FLUID RETENTION 81
389 HYPERSOMNIA 80
390 INJURY 80
391 JOINT STIFFNESS 80
392 PHOTOPHOBIA 80
393 RESPIRATORY FAILURE 80
394 RESPIRATORY TRACT INFECTION 80
395 RIB FRACTURE 80
396 SINUS DISORDER 80
397 SKIN DISCOLOURATION 80
398 WHITE BLOOD CELL COUNT INCREASED 80
399 AGITATION 79
400 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 79
401 HERNIA 79
402 LOCALISED INFECTION 79
403 SKIN CANCER 79
404 WOUND 79
405 ARRHYTHMIA 78
406 BENIGN PROSTATIC HYPERPLASIA 78
407 CARDIAC ARREST 78
408 CHOLELITHIASIS 78
409 DEEP VEIN THROMBOSIS 78
410 HEAD INJURY 78
411 SEPTIC SHOCK 78
412 APHONIA 77
413 BLOOD PRESSURE DIASTOLIC INCREASED 77
414 NOCTURIA 77
415 SECRETION DISCHARGE 77
416 TOOTH DISORDER 77
417 BLOOD PRESSURE SYSTOLIC ABNORMAL 76
418 DRUG TOLERANCE 76
419 INTERVERTEBRAL DISC PROTRUSION 76
420 LIP SWELLING 76
421 MALIGNANT NEOPLASM PROGRESSION 76
422 ANGINA PECTORIS 75
423 DRUG TOLERANCE DECREASED 75
424 INTENTIONAL DOSE OMISSION 75
425 NODULE 75
426 SINUS CONGESTION 75
427 DYSSTASIA 74
428 EATING DISORDER 74
429 HALLUCINATION 74
430 INFUSION SITE PAIN 73
431 INJECTION SITE PRURITUS 73
432 IRRITABILITY 73
433 POOR QUALITY SLEEP 73
434 ANGIOEDEMA 72
435 BREATH SOUNDS ABNORMAL 72
436 MOUTH ULCERATION 72
437 PROTEINURIA 72
438 THERAPY CESSATION 71
439 DISEASE PROGRESSION 70
440 GASTROENTERITIS 70
441 HYPOTHYROIDISM 70
442 SKIN DISORDER 70
443 BLOOD PRESSURE SYSTOLIC DECREASED 69
444 DRUG EFFECT DECREASED 69
445 NIGHT SWEATS 69
446 BRADYCARDIA 68
447 CONGENITAL HIATUS HERNIA 68
448 HYPERTENSIVE NEPHROPATHY 68
449 LETHARGY 68
450 PELVIC PAIN 68
451 RESPIRATORY DISORDER 68
452 CONJUNCTIVITIS 67
453 DEPRESSED MOOD 67
454 FAECES DISCOLOURED 67
455 GASTROENTERITIS VIRAL 67
456 MASS 67
457 MIDDLE INSOMNIA 67
458 SCIATICA 67
459 TENDERNESS 67
460 TOOTH INFECTION 67
461 CREPITATIONS 66
462 DYSKINESIA 66
463 HEPATIC STEATOSIS 66
464 PHARYNGITIS 66
465 UNDERDOSE 66
466 CANDIDA INFECTION 65
467 CLOSTRIDIUM DIFFICILE COLITIS 65
468 EYE SWELLING 65
469 INJECTION SITE WARMTH 65
470 RENAL PAIN 65
471 TYPE 2 DIABETES MELLITUS 65
472 URINARY RETENTION 65
473 FLANK PAIN 64
474 HYPOACUSIS 64
475 JOINT RANGE OF MOTION DECREASED 64
476 MULTIPLE SCLEROSIS 64
477 RASH ERYTHEMATOUS 64
478 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64
479 GRANULOMA 63
480 IMPAIRED HEALING 63
481 JOINT EFFUSION 63
482 PRESYNCOPE 63
483 PULMONARY OEDEMA 63
484 SKIN LESION 63
485 ACUTE RESPIRATORY FAILURE 62
486 MUSCULOSKELETAL CHEST PAIN 62
487 MUSCULOSKELETAL DISCOMFORT 62
488 STAPHYLOCOCCAL INFECTION 62
489 ANKLE FRACTURE 61
490 BREAST CANCER 61
491 LEUKOPENIA 61
492 PHARYNGITIS STREPTOCOCCAL 61
493 TOOTHACHE 61
494 DEFAECATION URGENCY 60
495 ERUCTATION 60
496 NIGHTMARE 60
497 ANTINUCLEAR ANTIBODY POSITIVE 59
498 BLOOD PRESSURE ABNORMAL 59
499 MALIGNANT MELANOMA STAGE 0 59
500 MULTIPLE SCLEROSIS RELAPSE 59
501 PRESCRIBED OVERDOSE 59
502 BLINDNESS 58
503 ORAL PAIN 58
504 SKIN IRRITATION 58
505 THERAPEUTIC REACTION TIME DECREASED 58
506 WEIGHT FLUCTUATION 58
507 HYPERKALAEMIA 57
508 RESPIRATORY SYMPTOM 57
509 THROMBOCYTOPENIA 57
510 HAND DEFORMITY 56
511 BLADDER DISORDER 55
512 DISORIENTATION 55
513 FEELING COLD 55
514 PANIC ATTACK 55
515 PROCEDURAL PAIN 55
516 PULMONARY THROMBOSIS 55
517 RASH MACULO-PAPULAR 55
518 SYNOVIAL CYST 55
519 ANKYLOSING SPONDYLITIS 54
520 CHOKING 53
521 COGNITIVE DISORDER 53
522 EYE DISORDER 53
523 HIP FRACTURE 53
524 OESOPHAGITIS 53
525 RESTLESS LEGS SYNDROME 53
526 CARDIO-RESPIRATORY ARREST 52
527 DRUG EFFECT INCOMPLETE 52
528 GALLBLADDER DISORDER 52
529 MOOD ALTERED 52
530 ANAL INCONTINENCE 51
531 BARRETT^S OESOPHAGUS 51
532 DIABETIC NEPHROPATHY 51
533 GLOSSODYNIA 51
534 HEAD DISCOMFORT 51
535 LACRIMATION INCREASED 51
536 LOWER LIMB FRACTURE 51
537 NEEDLE ISSUE 51
538 ORAL CANDIDIASIS 51
539 POLYP 51
540 RESPIRATORY TRACT CONGESTION 51
541 UPPER GASTROINTESTINAL HAEMORRHAGE 51
542 VITAMIN D DEFICIENCY 51
543 WITHDRAWAL SYNDROME 51
544 DRUG WITHDRAWAL SYNDROME 50
545 HEPATIC CIRRHOSIS 50
546 HYPOPHAGIA 50
547 MUSCLE STRAIN 50
548 OBESITY 50
549 RASH GENERALISED 50
550 VAGINAL HAEMORRHAGE 50
551 WRONG TECHNIQUE IN DRUG USAGE PROCESS 50
552 ALLERGY TO CHEMICALS 49
553 BLOOD COUNT ABNORMAL 49
554 BLOOD MAGNESIUM DECREASED 49
555 BODY TEMPERATURE INCREASED 49
556 COMPLETED SUICIDE 49
557 CUSHINGOID 49
558 DIABETES MELLITUS INADEQUATE CONTROL 49
559 ESSENTIAL HYPERTENSION 49
560 FORCED EXPIRATORY VOLUME DECREASED 49
561 MUCOSAL INFLAMMATION 49
562 MULTIPLE FRACTURES 49
563 ABDOMINAL PAIN LOWER 48
564 BLOOD URINE PRESENT 48
565 DEFORMITY 48
566 GAIT INABILITY 48
567 RHEUMATOID LUNG 48
568 SCOLIOSIS 48
569 SENSORY DISTURBANCE 48
570 SMALL INTESTINAL OBSTRUCTION 48
571 ABNORMAL FAECES 47
572 ACCIDENT 47
573 ACCIDENTAL EXPOSURE TO PRODUCT 47
574 BODY HEIGHT DECREASED 47
575 DRY THROAT 47
576 FRUSTRATION TOLERANCE DECREASED 47
577 KNEE ARTHROPLASTY 47
578 ORAL DISCOMFORT 47
579 PRE-EXISTING CONDITION IMPROVED 47
580 ROTATOR CUFF SYNDROME 47
581 TERMINAL INSOMNIA 47
582 UPPER LIMB FRACTURE 47
583 APHASIA 46
584 CRYING 46
585 LUNG NEOPLASM MALIGNANT 46
586 PALLOR 46
587 PNEUMONITIS 46
588 POST PROCEDURAL COMPLICATION 46
589 PRODUCT DOSE OMISSION IN ERROR 46
590 PRURITUS GENERALISED 46
591 TENOSYNOVITIS STENOSANS 46
592 ACUTE MYOCARDIAL INFARCTION 45
593 ALTERED STATE OF CONSCIOUSNESS 45
594 BLOOD GLUCOSE DECREASED 45
595 BONE DISORDER 45
596 EYE PRURITUS 45
597 INSURANCE ISSUE 45
598 SKIN BURNING SENSATION 45
599 TREATMENT NONCOMPLIANCE 45
600 ABNORMAL DREAMS 44
601 ANAL FISSURE 44
602 DERMATITIS CONTACT 44
603 DIPLOPIA 44
604 FOOT DEFORMITY 44
605 INTERVERTEBRAL DISC DEGENERATION 44
606 MENTAL IMPAIRMENT 44
607 PANCYTOPENIA 44
608 PRODUCT ADMINISTRATION ERROR 44
609 RETCHING 44
610 SPINAL OSTEOARTHRITIS 44
611 UVEITIS 44
612 CHOLECYSTECTOMY 43
613 CYST 43
614 DRUG SPECIFIC ANTIBODY PRESENT 43
615 EXPIRED PRODUCT ADMINISTERED 43
616 GASTROINTESTINAL INFECTION 43
617 INFUSION SITE ERYTHEMA 43
618 MUCOUS STOOLS 43
619 PULMONARY TOXICITY 43
620 QUALITY OF LIFE DECREASED 43
621 COLD SWEAT 42
622 DYSARTHRIA 42
623 HAEMATOMA 42
624 HYPOGLYCAEMIA 42
625 LYMPHOMA 42
626 MENTAL DISORDER 42
627 SCLERITIS 42
628 BACK DISORDER 41
629 HYPERAESTHESIA 41
630 INJECTION SITE EXTRAVASATION 41
631 IRON DEFICIENCY ANAEMIA 41
632 LIGAMENT SPRAIN 41
633 MEDICATION ERROR 41
634 OSTEOPENIA 41
635 RESPIRATORY RATE INCREASED 41
636 SNEEZING 41
637 WRIST FRACTURE 41
638 DEAFNESS 40
639 DRUG-INDUCED LIVER INJURY 40
640 ECZEMA 40
641 IMMUNODEFICIENCY 40
642 PHARYNGEAL SWELLING 40
643 PRODUCT PRESCRIBING ERROR 40
644 SJOGREN^S SYNDROME 40
645 SPINAL OPERATION 40
646 CORONARY ARTERY OCCLUSION 39
647 ENTERITIS 39
648 EXOSTOSIS 39
649 EYE HAEMORRHAGE 39
650 HUNGER 39
651 METABOLIC ACIDOSIS 39
652 PYELONEPHRITIS 39
653 TASTE DISORDER 39
654 UPPER-AIRWAY COUGH SYNDROME 39
655 DIARRHOEA HAEMORRHAGIC 38
656 LARGE INTESTINE POLYP 38
657 PNEUMONIA ASPIRATION 38
658 RAYNAUD^S PHENOMENON 38
659 VASCULITIS 38
660 BACTEROIDES INFECTION 37
661 DEMENTIA 37
662 DIVERTICULUM 37
663 DRUG EFFECT LESS THAN EXPECTED 37
664 EMOTIONAL DISORDER 37
665 GASTRIC POLYPS 37
666 HYPOCALCAEMIA 37
667 IMPAIRED QUALITY OF LIFE 37
668 NERVE COMPRESSION 37
669 PERICARDIAL EFFUSION 37
670 RESTLESSNESS 37
671 RHINITIS 37
672 SKIN INFECTION 37
673 VITAMIN D DECREASED 37
674 AUTOIMMUNE DISORDER 36
675 BLOOD GLUCOSE ABNORMAL 36
676 DERMATITIS 36
677 DISABILITY 36
678 GASTROINTESTINAL INFLAMMATION 36
679 GASTROINTESTINAL PAIN 36
680 HAIR TEXTURE ABNORMAL 36
681 INFUSION SITE SWELLING 36
682 PERICARDITIS 36
683 RENAL MASS 36
684 RESPIRATION ABNORMAL 36
685 SKIN FISSURES 36
686 SYNOVIAL FLUID ANALYSIS 36
687 ANHEDONIA 35
688 ARTERIOSCLEROSIS 35
689 EAR DISCOMFORT 35
690 FISTULA 35
691 MULTIPLE ALLERGIES 35
692 NERVOUS SYSTEM DISORDER 35
693 POST-TRAUMATIC STRESS DISORDER 35
694 REGURGITATION 35
695 RESPIRATORY DISTRESS 35
696 SHOCK 35
697 URINE ODOUR ABNORMAL 35
698 VAGINAL INFECTION 35
699 BRONCHOSPASM 34
700 DRUG PRESCRIBING ERROR 34
701 GLAUCOMA 34
702 HAEMATEMESIS 34
703 INJECTION SITE RASH 34
704 LIVER INJURY 34
705 MATERNAL EXPOSURE DURING PREGNANCY 34
706 MUSCLE TWITCHING 34
707 PRODUCT AVAILABILITY ISSUE 34
708 PRODUCT STORAGE ERROR 34
709 PULMONARY FUNCTION TEST DECREASED 34
710 SENSATION OF FOREIGN BODY 34
711 SPINAL FRACTURE 34
712 BLOOD BILIRUBIN INCREASED 33
713 DECREASED IMMUNE RESPONSIVENESS 33
714 FOLLICULITIS 33
715 GASTROINTESTINAL MOTILITY DISORDER 33
716 HEART RATE ABNORMAL 33
717 KNEE OPERATION 33
718 POST PROCEDURAL INFECTION 33
719 POSTOPERATIVE WOUND INFECTION 33
720 RASH PAPULAR 33
721 SCRATCH 33
722 BACTERAEMIA 32
723 DELIRIUM 32
724 DRUG LEVEL DECREASED 32
725 ECCHYMOSIS 32
726 FULL BLOOD COUNT DECREASED 32
727 HELICOBACTER INFECTION 32
728 HIP ARTHROPLASTY 32
729 HYPOMAGNESAEMIA 32
730 IMMUNE SYSTEM DISORDER 32
731 INFUSION SITE EXTRAVASATION 32
732 LOCAL SWELLING 32
733 MUSCLE TIGHTNESS 32
734 ORTHOSTATIC HYPOTENSION 32
735 PAIN OF SKIN 32
736 PARKINSON^S DISEASE 32
737 PHARYNGEAL OEDEMA 32
738 PNEUMOTHORAX 32
739 SARS-COV-2 TEST POSITIVE 32
740 SCLERODERMA 32
741 SENSITIVITY TO WEATHER CHANGE 32
742 SKIN LACERATION 32
743 ANAPHYLACTIC SHOCK 31
744 APHTHOUS ULCER 31
745 BIPOLAR DISORDER 31
746 CONCUSSION 31
747 HEPATITIS 31
748 INTENTIONAL OVERDOSE 31
749 LARYNGITIS 31
750 MADAROSIS 31
751 MENISCUS INJURY 31
752 OESOPHAGEAL DISORDER 31
753 TOOTH ABSCESS 31
754 ABASIA 30
755 ANAL ABSCESS 30
756 ANGER 30
757 ANORECTAL DISCOMFORT 30
758 BEDRIDDEN 30
759 BLOOD ALKALINE PHOSPHATASE ABNORMAL 30
760 DEVICE RELATED INFECTION 30
761 GENERALISED OEDEMA 30
762 HEPATOTOXICITY 30
763 HYPOAESTHESIA ORAL 30
764 NERVE INJURY 30
765 RENAL CANCER 30
766 ABSCESS 29
767 BLOOD DISORDER 29
768 COVID-19 PNEUMONIA 29
769 GLOMERULAR FILTRATION RATE DECREASED 29
770 HAEMOGLOBIN INCREASED 29
771 HAIR COLOUR CHANGES 29
772 IMMUNOSUPPRESSION 29
773 LYMPHOCYTE COUNT DECREASED 29
774 METASTASES TO LIVER 29
775 PARAESTHESIA ORAL 29
776 POLYURIA 29
777 STREPTOCOCCAL INFECTION 29
778 SUICIDE ATTEMPT 29
779 THINKING ABNORMAL 29
780 BLINDNESS UNILATERAL 28
781 DEVICE LEAKAGE 28
782 ENCEPHALOPATHY 28
783 FRACTURE 28
784 HAEMODIALYSIS 28
785 HEPATOMEGALY 28
786 HYDRONEPHROSIS 28
787 INCONTINENCE 28
788 INCREASED UPPER AIRWAY SECRETION 28
789 INFUSION SITE HAEMORRHAGE 28
790 MOOD SWINGS 28
791 OESOPHAGEAL PAIN 28
792 PRESCRIBED UNDERDOSE 28
793 PRODUCT ADHESION ISSUE 28
794 SCAR 28
795 SPINAL DISORDER 28
796 TOOTH EXTRACTION 28
797 URINE OUTPUT DECREASED 28
798 ADRENAL INSUFFICIENCY 27
799 AGEUSIA 27
800 BLOOD SODIUM DECREASED 27
801 COELIAC DISEASE 27
802 COMA 27
803 FEAR 27
804 HAEMATOCRIT DECREASED 27
805 JOINT DISLOCATION 27
806 MAJOR DEPRESSION 27
807 ODYNOPHAGIA 27
808 PERIPHERAL COLDNESS 27
809 SINUS PAIN 27
810 SKIN HAEMORRHAGE 27
811 SPINAL PAIN 27
812 TOTAL LUNG CAPACITY INCREASED 27
813 WRONG PRODUCT ADMINISTERED 27
814 BOWEL MOVEMENT IRREGULARITY 26
815 BREAST MASS 26
816 CONVULSION 26
817 EPILEPSY 26
818 FACIAL PARALYSIS 26
819 GINGIVAL PAIN 26
820 HAND FRACTURE 26
821 HYPERGLYCAEMIA 26
822 IMPAIRED DRIVING ABILITY 26
823 INCREASED APPETITE 26
824 INFLAMMATORY BOWEL DISEASE 26
825 INFUSION SITE PRURITUS 26
826 INITIAL INSOMNIA 26
827 PLATELET COUNT INCREASED 26
828 PROCTALGIA 26
829 PRODUCT ADMINISTRATION INTERRUPTED 26
830 PULMONARY HYPERTENSION 26
831 SYNOVIAL DISORDER 26
832 THYROID DISORDER 26
833 TOOTH LOSS 26
834 URINE ABNORMALITY 26
835 APPETITE DISORDER 25
836 BLOOD IMMUNOGLOBULIN E INCREASED 25
837 CYTOKINE RELEASE SYNDROME 25
838 DERMATITIS ATOPIC 25
839 DYSPNOEA AT REST 25
840 ELECTROLYTE IMBALANCE 25
841 EPIGASTRIC DISCOMFORT 25
842 FACIAL PAIN 25
843 GRIP STRENGTH DECREASED 25
844 INJECTION SITE URTICARIA 25
845 INTENTIONAL DRUG MISUSE 25
846 LUNG INFECTION 25
847 MENORRHAGIA 25
848 MENTAL STATUS CHANGES 25
849 MITRAL VALVE INCOMPETENCE 25
850 NEOPLASM PROGRESSION 25
851 OVARIAN CYST 25
852 PHOTOSENSITIVITY REACTION 25
853 PRODUCT PHYSICAL ISSUE 25
854 PSYCHOLOGICAL TRAUMA 25
855 PULMONARY CONGESTION 25
856 RENAL ATROPHY 25
857 SKIN REACTION 25
858 TOOTH FRACTURE 25
859 VIRAL UPPER RESPIRATORY TRACT INFECTION 25
860 VITAMIN B12 DEFICIENCY 25
861 WOUND INFECTION 25
862 ABDOMINAL HERNIA 24
863 BLOOD CREATINE PHOSPHOKINASE INCREASED 24
864 BREAST PAIN 24
865 EAR DISORDER 24
866 ECHOCARDIOGRAM ABNORMAL 24
867 EOSINOPHIL COUNT INCREASED 24
868 FEMUR FRACTURE 24
869 FOOD POISONING 24
870 HEAVY MENSTRUAL BLEEDING 24
871 HEREDITARY ANGIOEDEMA 24
872 HYPERVOLAEMIA 24
873 HYPOKINESIA 24
874 INCREASED TENDENCY TO BRUISE 24
875 OROPHARYNGEAL DISCOMFORT 24
876 PRODUCT DISPENSING ERROR 24
877 SCAB 24
878 STENT PLACEMENT 24
879 TENDON RUPTURE 24
880 THIRST 24
881 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 24
882 AGGRESSION 23
883 BRAIN NEOPLASM 23
884 CENTRAL OBESITY 23
885 CONJUNCTIVAL HAEMORRHAGE 23
886 ECONOMIC PROBLEM 23
887 ENERGY INCREASED 23
888 FAECAL CALPROTECTIN INCREASED 23
889 KLEBSIELLA BACTERAEMIA 23
890 LABORATORY TEST ABNORMAL 23
891 NASAL DRYNESS 23
892 OESOPHAGEAL ULCER 23
893 PEAK EXPIRATORY FLOW RATE DECREASED 23
894 PHOTOPSIA 23
895 PNEUMOCOCCAL INFECTION 23
896 PSYCHOMOTOR HYPERACTIVITY 23
897 RENAL HYPERTENSION 23
898 SEDATION 23
899 SEROTONIN SYNDROME 23
900 WALKING AID USER 23
901 ABNORMAL BEHAVIOUR 22
902 AMENORRHOEA 22
903 ARTERIOVENOUS FISTULA OCCLUSION 22
904 BLOOD LACTIC ACID INCREASED 22
905 CENTRAL NERVOUS SYSTEM LESION 22
906 DEFAECATION DISORDER 22
907 DEMENTIA ALZHEIMER^S TYPE 22
908 DIVERTICULUM INTESTINAL 22
909 DUODENAL ULCER 22
910 DYSTONIA 22
911 FACET JOINT SYNDROME 22
912 HAEMORRHOIDAL HAEMORRHAGE 22
913 HAIR DISORDER 22
914 HICCUPS 22
915 HYPERTHYROIDISM 22
916 LIVER FUNCTION TEST ABNORMAL 22
917 LOWER GASTROINTESTINAL HAEMORRHAGE 22
918 MUSCLE ATROPHY 22
919 NEPHROSCLEROSIS 22
920 OSTEONECROSIS 22
921 RENAL NEOPLASM 22
922 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22
923 RESTRICTIVE PULMONARY DISEASE 22
924 SENSITIVE SKIN 22
925 SERUM AMYLOID A PROTEIN INCREASED 22
926 SKIN PLAQUE 22
927 TRANSFUSION 22
928 TRIGGER FINGER 22
929 ACTIVITIES OF DAILY LIVING IMPAIRED 21
930 BLUE TOE SYNDROME 21
931 CEREBRAL HAEMORRHAGE 21
932 CONCOMITANT DISEASE AGGRAVATED 21
933 DECREASED ACTIVITY 21
934 DEVICE BREAKAGE 21
935 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21
936 DUODENAL ULCER PERFORATION 21
937 EYE INFECTION 21
938 GINGIVAL BLEEDING 21
939 GROIN PAIN 21
940 INFUSION SITE BRUISING 21
941 INJECTION SITE OEDEMA 21
942 INTERNAL HAEMORRHAGE 21
943 LYMPHOPENIA 21
944 MACULOPATHY 21
945 MANIA 21
946 MYDRIASIS 21
947 NEOPLASM 21
948 PNEUMONIA BACTERIAL 21
949 POLYARTHRITIS 21
950 PSYCHIATRIC SYMPTOM 21
951 ROSACEA 21
952 VISUAL ACUITY REDUCED 21
953 VITREOUS FLOATERS 21
954 ABDOMINAL RIGIDITY 20
955 APPLICATION SITE ERYTHEMA 20
956 APPLICATION SITE PRURITUS 20
957 BACK INJURY 20
958 BRAIN FOG 20
959 BRONCHIAL DISORDER 20
960 CALCIUM DEFICIENCY 20
961 ERYTHEMA OF EYELID 20
962 EXTRASYSTOLES 20
963 EYE INFLAMMATION 20
964 GASTROINTESTINAL TOXICITY 20
965 GENERALISED ERYTHEMA 20
966 GINGIVITIS 20
967 GLYCOSYLATED HAEMOGLOBIN INCREASED 20
968 LEUKOCYTOSIS 20
969 LIGAMENT RUPTURE 20
970 LOCALISED OEDEMA 20
971 PEPTIC ULCER 20
972 POOR QUALITY PRODUCT ADMINISTERED 20
973 PRODUCT USE COMPLAINT 20
974 RENAL COLIC 20
975 RHABDOMYOLYSIS 20
976 SPINAL STENOSIS 20
977 SPRUE-LIKE ENTEROPATHY 20
978 SYRINGE ISSUE 20
979 TEMPERATURE INTOLERANCE 20
980 TONSILLITIS 20
981 URINARY HESITATION 20
982 URINARY TRACT DISORDER 20
983 VULVOVAGINAL DRYNESS 20
984 ACCIDENTAL OVERDOSE 19
985 APPLICATION SITE PAIN 19
986 ARTHROPOD BITE 19
987 BLOOD POTASSIUM INCREASED 19
988 BLOOD THYROID STIMULATING HORMONE INCREASED 19
989 BLOOD TRIGLYCERIDES INCREASED 19
990 BONE HYPERTROPHY 19
991 CARDIAC FLUTTER 19
992 CARDIOMYOPATHY 19
993 CERVIX NEOPLASM 19
994 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 19
995 COLITIS MICROSCOPIC 19
996 DRUG ADMINISTRATION ERROR 19
997 DRUG LEVEL BELOW THERAPEUTIC 19
998 ELECTROCARDIOGRAM QT PROLONGED 19
999 EMPHYSEMA 19